Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
Colorcon
Cerilliant
Farmers Insurance
Queensland Health
UBS
McKinsey
Express Scripts
Chinese Patent Office
Fish and Richardson

Generated: February 25, 2018

DrugPatentWatch Database Preview

CYCLOGYL Drug Profile

« Back to Dashboard

Which patents cover Cyclogyl, and what generic alternatives are available?

Cyclogyl is a drug marketed by Novartis Pharms Corp and is included in three NDAs.

The generic ingredient in CYCLOGYL is cyclopentolate hydrochloride. There are two drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the cyclopentolate hydrochloride profile page.
Drug patent expirations by year for CYCLOGYL
Medical Subject Heading (MeSH) Categories for CYCLOGYL

US Patents and Regulatory Information for CYCLOGYL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis Pharms Corp CYCLOGYL cyclopentolate hydrochloride SOLUTION/DROPS;OPHTHALMIC 084109-001 Approved Prior to Jan 1, 1982 AT RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Novartis Pharms Corp CYCLOGYL cyclopentolate hydrochloride SOLUTION/DROPS;OPHTHALMIC 084110-001 Approved Prior to Jan 1, 1982 AT RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Novartis Pharms Corp CYCLOGYL cyclopentolate hydrochloride SOLUTION/DROPS;OPHTHALMIC 084108-001 Approved Prior to Jan 1, 1982 RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Argus Health
Farmers Insurance
Teva
Johnson and Johnson
Mallinckrodt
Chubb
UBS
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot